Global Bruxism Management Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Bruxism or teeth grinding refers to repetitive clenching and grinding of Jaws. In this condition patient clench teeth unconsciously while awake or while sleeping. Awake bruxism happens due factors such as anxiety, stress, anger, frustration, and tension. Whereas Sleep bruxism is associated with sleep arousals. Growing prevalence of neurological disorders and increasing cases of sleep apnea are key drivers for growth of Bruxism Management Market. For instance, according to Pan American Health Organization - In 2019, in United States, Neurological conditions account for around 533,172 deaths. Further, 213,129 (40%) men lost their life , and 320,043 (60%) women died due to neurological conditions. Furthermore, as per Parkinson's Foundation- In 2020, around 930,000 people in the U.S. were diagnosed with Perkinson's disease and this number is projected to increase to 1.2 million by 2030. Also, growing healthcare spending in emerging markets and rising pediatric population are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high treatment cost associated with Bruxism hinders the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Bruxism Management Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising prevalence of stress and anxiety related diseases and presence of leading market players in the region . Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising healthcare industry in the emerging countries and growing instances of neurological disorders in the region, would create lucrative growth prospects for the Bruxism Management market across the North American region.
Major market players included in this report are:
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Eli Lilly and Company
Mayne Pharma
Cadila Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Pfizer
Endo International plc
Akervall Technologies, Inc.
Mylan N.V.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Diurnal Bruxism
Nocturnal Bruxism
By Treatment Type
Drugs
Antianxiety Agents
Tranquilizers
Sedatives
Muscle Relaxants
Dental Approaches
Occlusal Splint
Mouth Guard
By Cause
Obstructive Sleep Apnea
Sleep Paralysis
Malocclusion
Gastroesophageal Reflux Disease (GERD)
Depression
Anxiety
Others
By Distribution Channel
Institutional Sales
Hospital
Dental Clinic
Retail Sales
Drug Store
Retail Store
Supermarket
Mail Order Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Bruxism Management Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Global Bruxism Management Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Global Bruxism Management Market, by Type, 2020-2028 (USD Million)
- 1.2.3. Global Bruxism Management Market, by Treatment Type, 2020-2028 (USD Million)
- 1.2.4. Global Bruxism Management Market, by Cause, 2020-2028 (USD Million)
- 1.2.5. Global Bruxism Management Market, by Distribution Channel, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Bruxism Management Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Bruxism Management Market Dynamics
- 3.1. Bruxism Management Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising prevalence of neurological disorders
- 3.1.1.2. Growing cases of sleep apnea
- 3.1.1.3. Increasing instances of stress and anxiety
- 3.1.2. Market Challenges
- 3.1.2.1. High-cost treatment.
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing healthcare spending in emerging markets
- 3.1.3.2. Increasing paediatric population.
Chapter 4. Global Bruxism Management Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Bruxism Management Market, by Type
- 6.1. Market Snapshot
- 6.2. Global Bruxism Management Market by Type, Performance - Potential Analysis
- 6.3. Global Bruxism Management Market Estimates & Forecasts by Type 2018-2028 (USD Million)
- 6.4. Bruxism Management Market, Sub Segment Analysis
- 6.4.1. Diurnal Bruxism
- 6.4.2. Nocturnal Bruxism
Chapter 7. Global Bruxism Management Market, by Treatment Type
- 7.1. Market Snapshot
- 7.2. Global Bruxism Management Market by Treatment Type, Performance - Potential Analysis
- 7.3. Global Bruxism Management Market Estimates & Forecasts by Treatment Type 2018-2028 (USD Million)
- 7.4. Bruxism Management Market, Sub Segment Analysis
- 7.4.1. Drugs
- 7.4.2. Antianxiety Agents
- 7.4.3. Tranquilizers
- 7.4.4. Sedatives
- 7.4.5. Muscle Relaxants
- 7.4.6. Dental Approaches
- 7.4.7. Occlusal Splint
- 7.4.8. Mouth Guard
Chapter 8. Global Bruxism Management Market, by Cause
- 8.1. Market Snapshot
- 8.2. Global Bruxism Management Market by Cause, Performance - Potential Analysis
- 8.3. Global Bruxism Management Market Estimates & Forecasts by Cause 2018-2028 (USD Million)
- 8.4. Bruxism Management Market, Sub Segment Analysis
- 8.4.1. Obstructive Sleep Apnea
- 8.4.2. Sleep Paralysis
- 8.4.3. Malocclusion
- 8.4.4. Gastroesophageal Reflux Disease (GERD)
- 8.4.5. Depression
- 8.4.6. Anxiety
- 8.4.7. Others
Chapter 9. Global Bruxism Management Market, by Distribution Channel
- 9.1. Market Snapshot
- 9.2. Global Bruxism Management Market by Distribution Channel, Performance - Potential Analysis
- 9.3. Global Bruxism Management Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)
- 9.4. Bruxism Management Market, Sub Segment Analysis
- 9.4.1. Institutional Sales
- 9.4.2. Hospital
- 9.4.3. Dental Clinic
- 9.4.4. Retail Sales
- 9.4.5. Drug Store
- 9.4.6. Retail Store
- 9.4.7. Supermarket
- 9.4.8. Mail Order Pharmacies
Chapter 10. Global Bruxism Management Market, Regional Analysis
- 10.1. Bruxism Management Market, Regional Market Snapshot
- 10.2. North America Bruxism Management Market
- 10.2.1. U.S. Bruxism Management Market
- 10.2.1.1. Type estimates & forecasts, 2018-2028
- 10.2.1.2. Treatment Type estimates & forecasts, 2018-2028
- 10.2.1.3. Cause estimates & forecasts, 2018-2028
- 10.2.1.4. Distribution Channel estimates & forecasts, 2018-2028
- 10.2.2. Canada Bruxism Management Market
- 10.3. Europe Bruxism Management Market Snapshot
- 10.3.1. U.K. Bruxism Management Market
- 10.3.2. Germany Bruxism Management Market
- 10.3.3. France Bruxism Management Market
- 10.3.4. Spain Bruxism Management Market
- 10.3.5. Italy Bruxism Management Market
- 10.3.6. Rest of Europe Bruxism Management Market
- 10.4. Asia-Pacific Bruxism Management Market Snapshot
- 10.4.1. China Bruxism Management Market
- 10.4.2. India Bruxism Management Market
- 10.4.3. Japan Bruxism Management Market
- 10.4.4. Australia Bruxism Management Market
- 10.4.5. South Korea Bruxism Management Market
- 10.4.6. Rest of Asia Pacific Bruxism Management Market
- 10.5. Latin America Bruxism Management Market Snapshot
- 10.5.1. Brazil Bruxism Management Market
- 10.5.2. Mexico Bruxism Management Market
- 10.6. Rest of The World Bruxism Management Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche AG
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. Product Summary
- 11.2.1.5. Recent Developments
- 11.2.2. GlaxoSmithKline plc
- 11.2.3. Eli Lilly and Company
- 11.2.4. Mayne Pharma
- 11.2.5. Cadila Pharmaceuticals
- 11.2.6. Teva Pharmaceutical Industries Ltd.
- 11.2.7. Pfizer
- 11.2.8. Endo International plc
- 11.2.9. Akervall Technologies, Inc.
- 11.2.10. Mylan N.V.
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption